BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 30787931)

  • 1. NKG2D and Its Ligand MULT1 Contribute to Disease Progression in a Mouse Model of Multiple Sclerosis.
    Legroux L; Moratalla AC; Laurent C; Deblois G; Verstraeten SL; Arbour N
    Front Immunol; 2019; 10():154. PubMed ID: 30787931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stress Signal ULBP4, an NKG2D Ligand, Is Upregulated in Multiple Sclerosis and Shapes CD8
    Carmena Moratalla A; Carpentier Solorio Y; Lemaitre F; Farzam-Kia N; Levert A; Zandee SEJ; Lahav B; Guimond JV; Haddad E; Girard M; Duquette P; Larochelle C; Prat A; Arbour N
    Neurol Neuroimmunol Neuroinflamm; 2022 Jan; 9(1):. PubMed ID: 34873031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inconsistence between number and function of autoreactive T cells in the course of experimental autoimmune encephalomyelitis.
    Wan X; Pei W; Zhang Y; Zhang L; Shahzad KA; Xu T; Shen C
    Immunol Invest; 2018 Jan; 47(1):1-17. PubMed ID: 28872930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stress-regulated targeting of the NKG2D ligand Mult1 by a membrane-associated RING-CH family E3 ligase.
    Nice TJ; Deng W; Coscoy L; Raulet DH
    J Immunol; 2010 Nov; 185(9):5369-76. PubMed ID: 20870941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
    Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
    Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.
    Sonobe Y; Jin S; Wang J; Kawanokuchi J; Takeuchi H; Mizuno T; Suzumura A
    Tohoku J Exp Med; 2007 Dec; 213(4):329-39. PubMed ID: 18075237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+NKG2D+ T cells exhibit enhanced migratory and encephalitogenic properties in neuroinflammation.
    Ruck T; Bittner S; Gross CC; Breuer J; Albrecht S; Korr S; Göbel K; Pankratz S; Henschel CM; Schwab N; Staszewski O; Prinz M; Kuhlmann T; Meuth SG; Wiendl H
    PLoS One; 2013; 8(11):e81455. PubMed ID: 24282598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detuning CD8+ T lymphocytes by down-regulation of the activating receptor NKG2D: role of NKG2D ligands released by activated T cells.
    Cerboni C; Ardolino M; Santoni A; Zingoni A
    Blood; 2009 Mar; 113(13):2955-64. PubMed ID: 19124832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NKG2D/NKG2DL Axis in the Crosstalk Between Lymphoid and Myeloid Cells in Health and Disease.
    Stojanovic A; Correia MP; Cerwenka A
    Front Immunol; 2018; 9():827. PubMed ID: 29740438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host T cells are the main producers of IL-17 within the central nervous system during initiation of experimental autoimmune encephalomyelitis induced by adoptive transfer of Th1 cell lines.
    Lees JR; Iwakura Y; Russell JH
    J Immunol; 2008 Jun; 180(12):8066-72. PubMed ID: 18523270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD134 plays a crucial role in the pathogenesis of EAE and is upregulated in the CNS of patients with multiple sclerosis.
    Carboni S; Aboul-Enein F; Waltzinger C; Killeen N; Lassmann H; Peña-Rossi C
    J Neuroimmunol; 2003 Dec; 145(1-2):1-11. PubMed ID: 14644025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
    Hammer LA; Waldner H; Zagon IS; McLaughlin PJ
    Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
    Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
    Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NKG2D receptor signaling enhances cytolytic activity by virus-specific CD8+ T cells: evidence for a protective role in virus-induced encephalitis.
    Walsh KB; Lanier LL; Lane TE
    J Virol; 2008 Mar; 82(6):3031-44. PubMed ID: 18160433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NKG2D mediates NK cell hyperresponsiveness and influenza-induced pathologies in a mouse model of chronic obstructive pulmonary disease.
    Wortham BW; Eppert BL; Motz GT; Flury JL; Orozco-Levi M; Hoebe K; Panos RJ; Maxfield M; Glasser SW; Senft AP; Raulet DH; Borchers MT
    J Immunol; 2012 May; 188(9):4468-75. PubMed ID: 22467655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis.
    Huseby ES; Liggitt D; Brabb T; Schnabel B; Ohlén C; Goverman J
    J Exp Med; 2001 Sep; 194(5):669-76. PubMed ID: 11535634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NKG2D signaling on CD8⁺ T cells represses T-bet and rescues CD4-unhelped CD8⁺ T cell memory recall but not effector responses.
    Zloza A; Kohlhapp FJ; Lyons GE; Schenkel JM; Moore TV; Lacek AT; O'Sullivan JA; Varanasi V; Williams JW; Jagoda MC; Bellavance EC; Marzo AL; Thomas PG; Zafirova B; Polić B; Al-Harthi L; Sperling AI; Guevara-Patiño JA
    Nat Med; 2012 Feb; 18(3):422-8. PubMed ID: 22366950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of TFH Cells in Promoting T Helper 17-Induced Neuroinflammation.
    Quinn JL; Kumar G; Agasing A; Ko RM; Axtell RC
    Front Immunol; 2018; 9():382. PubMed ID: 29535739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells.
    Matusali G; Tchidjou HK; Pontrelli G; Bernardi S; D'Ettorre G; Vullo V; Buonomini AR; Andreoni M; Santoni A; Cerboni C; Doria M
    FASEB J; 2013 Jun; 27(6):2440-50. PubMed ID: 23395909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific alterations in NKG2D
    Carmena Moratalla A; Carpentier Solorio Y; Lemaître F; Farzam-Kia N; Da Cal S; Guimond JV; Haddad E; Duquette P; Girard JM; Prat A; Larochelle C; Arbour N
    Mult Scler Relat Disord; 2023 Mar; 71():104542. PubMed ID: 36716577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.